Pharmaceutical Filtration Global Market Report 2024

The global pharmaceutical filtration market has grown strongly in recent years. It will grow from $6.96 billion in 2023 to $7.38 billion in 2024 at a compound annual growth rate (CAGR) of 6.0%. The growth observed in the historical period can be attributed to several factors, including rigorous adherence to regulatory standards, an increased emphasis on drug purity and safety, a rising prevalence of chronic diseases, and a concerted focus on cost-efficiency. These factors collectively contributed to the development and expansion of the pharmaceutical industry during the specified historical period.

The global pharmaceutical filtration market is expected to see strong growth in the next few years. It will grow to $9.21 billion in 2028 at a compound annual growth rate (CAGR) of 5.7%. The anticipated growth in the upcoming period can be linked to several factors such as the rapid expansion of personalized medicine, heightened attention on continuous manufacturing, the pressing demand for vaccine production amidst global outbreaks, the increasing need for aseptic processing, and the worldwide expansion of pharmaceutical markets. Notable trends expected in this period encompass the increasing uptake of single-use filtration technologies, a growing demand for sterilizing filtration, advancements in membrane filtration, a specific focus on virus filtration for bioprocessing, integration of filtration into single-use systems, and an emphasis on pre-filtration procedures.

The surge in demand for generic drugs is anticipated to drive the pharmaceutical filtration market's growth. Generic pharmaceuticals mimic approved brand-name drugs, and their production involves pharmaceutical filtration techniques that remove solid particulate matter from fluids. Notably, India, as of June 2022, supplies over 40% of generic drug demand in the U.S. and a quarter of pharmaceuticals in the U.K. This escalating demand for generic drugs significantly fuels the pharmaceutical filtration market.

The ascending prevalence of chronic diseases is poised to propel the pharmaceutical filtration market in the forthcoming years. Chronic illnesses, persisting over extended periods and not preventable with immunizations, have seen a global upsurge. Addressing this heightened output necessitates robust filtration methods to maintain product quality. For instance, as of March 2022, over three-quarters of Australians dealt with at least one long-term health issue, with almost half of the population encountering chronic illnesses. This rise in chronic diseases serves as a driving force for the pharmaceutical filtration market.

Product innovation stands as a prominent trend gaining traction in the pharmaceutical filtration sector. Companies within this market are diligently innovating, introducing advanced filtration methods like high-volume filtration plates. An example of this trend is seen in ANDRITZ, an Austria-based company, which, in November 2021, unveiled Nutrion, an innovative vacuum filter with enhanced features aimed at eliminating contamination risks and reducing downtime for cloth changes in the pharma and food industries.

Major players in the pharmaceutical filtration industry are strategically pursuing partnerships to enhance downstream purification processes for exosome production. Strategic partnerships involve leveraging mutual strengths and resources for mutual gains. Recently, in January 2023, RoosterBio Inc., a U.S. biopharmaceutical company, announced a collaboration with Germany-based Sartorius AG. This strategic alliance aims to provide top-notch solutions for manufacturing platforms focused on human mesenchymal stem/stromal cells (hMSCs) for exosome production, ensuring industry-leading potency, purity, and yield. The collaboration will emphasize developing comprehensive analytical methods for characterizing exosomes and other extracellular vesicles, leading to scalable filtration equipment and strategies for exosome purification.

In November 2021, Donaldson Company, a vertically integrated filtration company based in the U.S., completed the acquisition of Solaris Biotechnology for €41 million (USD 46.3 million). This strategic acquisition aligns with Donaldson Company's objective of expanding its footprint within the life sciences market. Solaris Biotechnology, headquartered in Italy, specializes in the design and production of bioprocessing equipment, encompassing fermenters, bioreactors, and tangential flow filtration systems.

Major companies operating in the pharmaceutical filtration market report are 3M Health Care, Danaher Corporation, Amazon Filters Ltd., Eaton Corporation PLC, GE Healthcare, Graver Technologies LLC, Meissner Filtration Products, Merck & Co. Inc., Parker Bioscience Filtration, Sartorius AG, Repligen, Porvair PLC, Alfa Laval AB, Corning Incorporated, Thermo Fisher Scientific, Freudenberg Group, Avantor Inc., Berry Global Inc., Cantel Medical Corp., Cole-Parmer Instrument Company LLC., Donaldson Company Inc., Entegris Inc., Filtration Group Corporation, Synder Filtration Inc., GVS S.p.A., Koch Membrane Systems Inc., Lenntech B.V., Mann+Hummel Group, Membrane Solutions, Pall Corporation

North America was the largest region in the pharmaceutical filtration market in 2023. The regions covered in the pharmaceutical filtration market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the pharmaceutical filtration market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The primary products within pharmaceutical filtration encompass membrane filters, prefilters, depth media, single-use systems, cartridges and capsules, filter holders, and filtration accessories. Membrane filters allow the flow of fluids or gases while obstructing the passage of particles and microorganisms. Techniques like microfiltration, ultrafiltration, crossflow filtration, and nanofiltration are employed across various operational scales including manufacturing, pilot studies, and research and development. These filtration methods find application in final product processing, raw material filtration, bioburden testing, cell separation, water purification, and air purification.

This report provides pharmaceutical filtration market statistics, including pharmaceutical filtration industry global market size, regional shares, competitors with a pharmaceutical filtration market share, detailed pharmaceutical filtration market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical filtration industry. This pharmaceutical filtration market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The pharmaceutical filtration market includes revenues earned by entities by providing reverse osmosis, sterile filtration, chromatography, sterile sampling and nanofiltration. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.